Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:77011rdf:typepubmed:Citationlld:pubmed
pubmed-article:77011lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:77011lifeskim:mentionsumls-concept:C0006280lld:lifeskim
pubmed-article:77011lifeskim:mentionsumls-concept:C0600260lld:lifeskim
pubmed-article:77011lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:77011lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:77011pubmed:issue5lld:pubmed
pubmed-article:77011pubmed:dateCreated1978-6-28lld:pubmed
pubmed-article:77011pubmed:abstractTextCromolyn sodium, oral and inhaled corticosteroids, antibiotics, and mucolytic agents all have a place in treatment of the reversible components of obstructive pulmonary disease. Patient education about the particular condition causing airflow obstruction and the chosen treatment program is extremely important in promoting patient acceptance.lld:pubmed
pubmed-article:77011pubmed:languageenglld:pubmed
pubmed-article:77011pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:citationSubsetAIMlld:pubmed
pubmed-article:77011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:77011pubmed:statusMEDLINElld:pubmed
pubmed-article:77011pubmed:monthMaylld:pubmed
pubmed-article:77011pubmed:issn0032-5481lld:pubmed
pubmed-article:77011pubmed:authorpubmed-author:PlummerA LALlld:pubmed
pubmed-article:77011pubmed:issnTypePrintlld:pubmed
pubmed-article:77011pubmed:volume63lld:pubmed
pubmed-article:77011pubmed:ownerNLMlld:pubmed
pubmed-article:77011pubmed:authorsCompleteYlld:pubmed
pubmed-article:77011pubmed:pagination113-9lld:pubmed
pubmed-article:77011pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Hu...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-An...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Ex...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Gl...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Lu...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Cr...lld:pubmed
pubmed-article:77011pubmed:meshHeadingpubmed-meshheading:77011-Be...lld:pubmed
pubmed-article:77011pubmed:year1978lld:pubmed
pubmed-article:77011pubmed:articleTitleChoosing a drug regimen for obstructive pulmonary disease. 2. Agents other than bronchodilators.lld:pubmed
pubmed-article:77011pubmed:publicationTypeJournal Articlelld:pubmed